{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F812ff1f7-c875-43f6-8c8f-79020ff33dc6","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Cases from the Community: Integrating New Research Findings into Current Practice \u2014 Leukemia and Myelodysplastic Syndromes\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/812ff1f7-c875-43f6-8c8f-79020ff33dc6\"></iframe>","title":"Cases from the Community: Integrating New Research Findings into Current Practice \u2014 Leukemia and Myelodysplastic Syndromes","description":"\n        <p>Dr Harry Paul Erba shares his perspectives on the evolving therapeutic landscape for patients with leukemia and myelodysplastic syndromes, moderated by Dr Stephen &quot;Fred&quot; Divers. Produced by Research To Practice. </p>\n\n<p>CME information and select publications <a href=\"https://www.researchtopractice.com/AON24\" rel=\"nofollow\">here</a>. </p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/0f6223e6-7e89-41d1-baa9-d783fcbf733f/cover.jpg"}